Sindhu Cherian

8.4k total citations · 5 hit papers
59 papers, 3.8k citations indexed

About

Sindhu Cherian is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Sindhu Cherian has authored 59 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 22 papers in Genetics. Recurrent topics in Sindhu Cherian's work include Lymphoma Diagnosis and Treatment (23 papers), CAR-T cell therapy research (21 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Sindhu Cherian is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), CAR-T cell therapy research (21 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Sindhu Cherian collaborates with scholars based in United States, Canada and United Kingdom. Sindhu Cherian's co-authors include David G. Maloney, Cameron J. Turtle, Stanley R. Riddell, Xueyan Chen, Laïla‐Aïcha Hanafi, Kevin A. Hay, Daniel Li, Brent L. Wood, Shelly Heimfeld and Lorinda Soma and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sindhu Cherian

54 papers receiving 3.7k citations

Hit Papers

Kinetics and biomarkers of severe cytokine release syndro... 2016 2026 2019 2022 2017 2016 2016 2017 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
    2017 775 citations Laïla‐Aïcha Hanafi, Sindhu Cherian et al. Blood profile →
  2. Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
    2016 741 citations Cameron J. Turtle, Laïla‐Aïcha Hanafi et al. profile →
  3. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
    2016 544 citations David Wu, Sindhu Cherian et al. Blood profile →
  4. Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
    2017 485 citations Cameron J. Turtle, Laïla‐Aïcha Hanafi et al. Journal of Clinical Oncology profile →
  5. Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
    2017 391 citations Sindhu Cherian, Xueyan Chen et al. Blood profile →

Peers

Sindhu Cherian
Craig S. Sauter United States
Saad S. Kenderian United States
Sunita D. Nasta United States
Caron A. Jacobson United States
Julio C. Chávez United States
Jakub Svoboda United States
Elena Mead United States
Rammurti T. Kamble United States
Armin Ghobadi United States
Maria Teresa Lupo Stanghellini Italy
Craig S. Sauter United States
Sindhu Cherian
Citations per year, relative to Sindhu Cherian Sindhu Cherian (= 1×) peers Craig S. Sauter

Countries citing papers authored by Sindhu Cherian

Since Specialization
Citations

This map shows the geographic impact of Sindhu Cherian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sindhu Cherian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sindhu Cherian more than expected).

Fields of papers citing papers by Sindhu Cherian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sindhu Cherian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sindhu Cherian. The network helps show where Sindhu Cherian may publish in the future.

Co-authorship network of co-authors of Sindhu Cherian

This figure shows the co-authorship network connecting the top 25 collaborators of Sindhu Cherian. A scholar is included among the top collaborators of Sindhu Cherian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sindhu Cherian. Sindhu Cherian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poh, Christina, Xueyan Chen, Jenna Voutsinas, et al.. (2025). Impact of immunophenotype on clinical disease characteristics and outcomes in T‐cell prolymphocytic leukaemia. British Journal of Haematology. 207(5). 2143–2146.
2.
Chen, Xueyan, Qi Gao, Mikhail Roshal, & Sindhu Cherian. (2023). Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy. Cytometry Part B Clinical Cytometry. 104(3). 205–223. 7 indexed citations
3.
Kopmar, Noam E., Ted Gooley, Sindhu Cherian, et al.. (2023). A phase I trial of dose-adjusted EPOCH plus inotuzumab ozogamicin (InO) in adults with relapsed/refractory (R/R) B lymphoblastic leukemia/lymphoma (B-ALL).. Journal of Clinical Oncology. 41(16_suppl). 7007–7007.
4.
Chen, Xueyan, Ulrika Johansson, & Sindhu Cherian. (2023). Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms. Clinics in Laboratory Medicine. 43(4). 521–547. 2 indexed citations
5.
Chen, Xueyan & Sindhu Cherian. (2021). Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia. Clinics in Laboratory Medicine. 41(3). 467–483. 3 indexed citations
6.
Reid, Molly C., et al.. (2021). Comparison of Blood Counts and Markers of Inflammation and Coagulation in Patients With and Without COVID-19 Presenting to the Emergency Department in Seattle, WA. American Journal of Clinical Pathology. 156(2). 185–197. 7 indexed citations
7.
Soma, Lorinda, Stephen D. Smith, Kerstin L. Edlefsen, et al.. (2021). Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal Mucosa. American Journal of Clinical Pathology. 157(1). 23–32. 2 indexed citations
8.
Chen, Xueyan & Sindhu Cherian. (2017). Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis. Clinics in Laboratory Medicine. 37(4). 753–769. 33 indexed citations
9.
10.
11.
Keel, Sioḃán, Raymond T. Doty, Li Liu, et al.. (2015). Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver. Experimental Hematology. 43(6). 469–478.e6. 22 indexed citations
12.
Turtle, Cameron J., Carolina Berger, Daniel Sommermeyer, et al.. (2015). Immunotherapy with CD19-specific chimeric antigen receptor (CAR)-modified T cells of defined subset composition.. Journal of Clinical Oncology. 33(15_suppl). 3006–3006. 13 indexed citations
13.
Roshal, Mikhail & Sindhu Cherian. (2012). Frequency of additional clonal populations detected by high sensitivity flow cytometry in patients with hairy cell leukemia. Journal of Hematopathology. 5(3). 123–130. 1 indexed citations
14.
Cherian, Sindhu, et al.. (2010). Evaluation of an 8‐color flow cytometric reference method for white blood cell differential enumeration. Cytometry Part B Clinical Cytometry. 78B(5). 319–328. 41 indexed citations
15.
Kalus, Andrea, John E. Olerud, Sindhu Cherian, et al.. (2007). CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T‐cell receptor gene rearrangement. Journal of Cutaneous Pathology. 35(6). 579–584. 17 indexed citations
16.
Cherian, Sindhu, Jonni S. Moore, Andrew Bantly, et al.. (2005). Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry Part B Clinical Cytometry. 64B(1). 9–17. 52 indexed citations
17.
Cherian, Sindhu, Jonni S. Moore, Andrew Bantly, et al.. (2005). Flow‐cytometric analysis of peripheral blood neutrophils: A simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes. American Journal of Hematology. 79(3). 243–245. 12 indexed citations
18.
Cherian, Sindhu, Rachel L. Sargent, Raja R. Seethala, et al.. (2005). Expanded Populations of Surface Membrane Immunoglobulin Light Chain–Negative B Cells in Lymph Nodes Are Not Always Indicative of B-Cell Lymphoma. American Journal of Clinical Pathology. 124(1). 143–150. 12 indexed citations
19.
Chong, Elise A., Jakub Svoboda, Sindhu Cherian, et al.. (2005). Regression of pulmonary MALT lymphoma after treatment with rituximab. Leukemia & lymphoma. 46(9). 1383–1386. 14 indexed citations
20.
Milovanova, Tatyana N., Sicco H. Popma, Sindhu Cherian, Jonni S. Moore, & Milton D. Rossman. (2004). Flow cytometric test for beryllium sensitivity. Cytometry Part B Clinical Cytometry. 60B(1). 23–30. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig S. Sauter Breakdown of academic impact, for papers by Saad S. Kenderian Breakdown of academic impact, for papers by Sunita D. Nasta Breakdown of academic impact, for papers by Caron A. Jacobson Breakdown of academic impact, for papers by Julio C. Chávez Breakdown of academic impact, for papers by Jakub Svoboda Breakdown of academic impact, for papers by Elena Mead Breakdown of academic impact, for papers by Rammurti T. Kamble Breakdown of academic impact, for papers by Armin Ghobadi Breakdown of academic impact, for papers by Maria Teresa Lupo Stanghellini
Rankless by CCL
2026